Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
NRG Oncology
Institut Cancerologie de l'Ouest
M.D. Anderson Cancer Center
Brigham and Women's Hospital
Stanford University
Wake Forest University Health Sciences
Filamon LTD
Fondazione del Piemonte per l'Oncologia
Aminex Therapeutics, Inc.
Hoffmann-La Roche
Psyence Australia Pty Ltd
ViroMissile, Inc.
Hummingbird Bioscience
Replimune Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Mayo Clinic
Washington University School of Medicine
University of Florida
Memorial Sloan Kettering Cancer Center
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Sapience Therapeutics
MacroGenics
Daiichi Sankyo
University of Nebraska
M.D. Anderson Cancer Center
Natera, Inc.
Second Life Therapeutics
Fusion Pharmaceuticals Inc.
University of Southern California
The Netherlands Cancer Institute
OncoNano Medicine, Inc.
Ohio State University Comprehensive Cancer Center
Mayo Clinic
The First Affiliated Hospital of Xinxiang Medical College
University Health Network, Toronto